Saroglitazar delivers positive Phase III results in rare liver disease PBC, U.S. filing planned 11 months ago JohnIn Pharma Industry UpdatesTop Stories
FDA approves Dupixent for chronic spontaneous urticaria in ages 12 and up 11 months ago JohnIn Breaking NewsFDA Approvals
FDA updates label for mavacamten after long-term studies show durable benefit in obstructive hypertrophic cardiomyopathy 11 months ago JohnIn BreakthroughsFDA ApprovalsResearch UpdatesTop Stories
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial 12 months ago JohnIn InvestmentsPeopleVenture Capital
EU Unveils Public Clinical Trial Map to Boost Transparency and Patient Access 12 months ago JohnIn Featured AnalysisTop Stories
WHO Sparks Global Clinical Trials Momentum with Forum to Fast-Track Innovation 12 months ago JohnIn BreakthroughsIndustry ConferencesResearch Updates
Australia Boosts Brain Cancer Research with $5.9 Million Grant for Innovative Chair 12 months ago JohnIn Biopharma HighlightsPartnershipsPeople
UK Sets Stage for Smoother Clinical Trials with New Law Expected by Mid-April 12 months ago JohnIn BreakthroughsClinical TrialsPeople
Emerging biotechs increasingly driving drug approvals, reshaping industry dynamics 12 months ago JohnIn Biopharma HighlightsClinical Trials
Precision Psychiatry Breakthrough: BH-200 Antidepressant Combined with Genetic Testing Delivers Strong Response in Major Depression Trial 12 months ago JohnIn Research UpdatesTop Stories
FDA approves novel immunotherapy combo for colorectal cancer and clears new surgery technology 12 months ago JohnIn DealsFDA ApprovalsResearch Updates
MHRA unveils first-ever analysis of UK clinical trial applications, offering new roadmap for research growth 12 months ago JohnIn Breaking NewsClinical TrialsFeatured Analysis
New clinical trial regulations take effect in the UK as pandemic case rates remain steady 12 months ago JohnIn Industry ConferencesPharma Industry UpdatesTop Stories
UK Unveils Major Push to Accelerate Clinical Trials and Health Data Access 12 months ago JohnIn Biopharma HighlightsFeatured AnalysisIndustry ConferencesResearch Updates
PTC Therapeutics reports promising Phase 2 results in Huntington’s disease program 12 months ago JohnIn Clinical TrialsFeatured AnalysisResearch UpdatesTop Stories
